genetics

Aluda Pharmaceuticals is a drug discovery company focused on novel targets for complex diseases, particularly immune and fibrotic diseases. It designs new drug molecules using tools including CRISPR, proteomic array analysis, genetics, molecular medicine, cell biology, big data, and chemical design, and pioneered proprietary concepts in phenotypic screening. Its lead program is a first-in-class anti-vimentin program for fibrosis.

big datacell biologychemical designCRISPRdrug discoverymolecular medicinephenotypic screeningproteomic array analysis

AquaSol, Inc. is a United States based aquaculture and fish farm consulting company providing expert opinions, technology transfer, and project management services to new and existing aquaculture projects worldwide. With over 25 years of experience across six continents, it offers feasibility studies, engineering and design, project development, investment advisory, and expert witness services for finfish, shellfish, and algae farming.

biosecurityengineering and designexpert witness testimonyfeasibility studieshatchery operationsNutritionproject managementrecirculating aquaculture system (RAS) designsite selectionvaluation

Bay Genomics, LLC is a Berkeley, CA based laboratory providing technology development for the life sciences. It helps clients develop cell models, genetic sequence analysis, cell culture work, drug testing, and proof-of-concept device development, and offers expertise in molecular biology, genetics, gene therapy, microscopy, histology, neuroscience, tissue culture, biochemistry, immunology, animal models of disease, bioinformatics, virus design, gene arrays, and sequencing. It is registered with SAM to subcontract on federal contracts and has experience

3D printinganimal models of diseasebiochemistryBioinformaticscomputer aided designgene arraysgene therapyhistologyimmunologyMicroscopymolecular biologyneurosciencePCB designphysiologypromoter bashingsequencingsolderingtissue culturevirus design

Instacare Therapeutics focuses on transforming basic scientific discoveries into practical therapeutic solutions aimed at improving public health, with emphasis on early clinical and translational research to achieve proof-of-concept milestones. The company develops innovative therapies for metabolic diseases, particularly obesity, hyperlipidemia, and fatty liver disease, using approaches in genetics, molecular biology, biotechnology, and artificial intelligence. Their research has identified key genes involved in metabolic disorders and led to developme

Artificial Intelligencebiotechnologyearly clinical and translational researchmolecular biology